Dymon Asia Capital »

Vertex Pharmaceuticals Incorporated shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 4.2k 453.36
2020-12-31 $496k 2.1k 236.19

More positions owned by Dymon Asia Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Silver Tr Ishares Call Option (SLV)
NVIDIA Corporation (NVDA)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Home Depot (HD)
Qualcomm (QCOM)
Synopsys Call Option (SNPS)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Dymon Asia Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated